Publication
What Has Changed During the COVID-19 Pandemic? - The Effect on an Academic Breast Department in Portugal
| dc.contributor.author | Simão, D | |
| dc.contributor.author | Sardinha, M | |
| dc.contributor.author | Reis, AF | |
| dc.contributor.author | Spencer, AS | |
| dc.contributor.author | Luz, R | |
| dc.contributor.author | Oliveira, S | |
| dc.date.accessioned | 2022-02-22T10:30:18Z | |
| dc.date.available | 2022-02-22T10:30:18Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Introduction: One year ago, Portugal entered its first lockdown because of the coronavirus disease-2019 (COVID-19) pandemic. The impact of this on delays in cancer diagnosis and treatment is a major concern, which may negatively affect the outcomes of these patients. Materials and methods: This retrospective, single-center analysis compared the clinical and pathological characteristics of breast cancer (BC) patients referred to a medical oncology first appointment between March 2020 and 2021, with the same period in the previous year. Results: Strikingly, there was a 40% reduction in the number of BC patients during lockdown. However, there was a statistically significant increase in the proportion of metastatic BC patients admitted for the first time for systemic therapy (13.6% vs. 28.9%, p = 0.003). Additionally, a statistically significant increase in the number of patients with bilateral early BC at diagnosis after March 2020 was found (7.2% vs. 1.9%, p = 0.043). Conclusion: These findings support international recommendations for an accelerated restoration of BC screening, to reduce incidence of advanced breast cancer at diagnosis and mitigate the expected impact of the COVID-19 pandemic on patients with cancer. Further work is needed to examine in detail the impact of measures to manage the COVID-19 pandemic on breast cancer outcomes. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Eur J Breast Health. 2022;18(1):74-78. | pt_PT |
| dc.identifier.doi | 10.4274/ejbh.galenos.2021.2021-11-1. | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/3972 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Galenos Publishing House | pt_PT |
| dc.subject | HSAC ONC | pt_PT |
| dc.subject | COVID-19 | pt_PT |
| dc.subject | SARS-CoV-2 | pt_PT |
| dc.subject | Breast Cancer | pt_PT |
| dc.subject | Oncology Department | pt_PT |
| dc.subject | Tertiary Hospital | pt_PT |
| dc.title | What Has Changed During the COVID-19 Pandemic? - The Effect on an Academic Breast Department in Portugal | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 78 | pt_PT |
| oaire.citation.startPage | 74 | pt_PT |
| oaire.citation.title | European Journal of Breast Health | pt_PT |
| oaire.citation.volume | 18 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Eur J Breast Health 2022 74.pdf
- Size:
- 268.04 KB
- Format:
- Adobe Portable Document Format